O	0	1	[	[	(	O
O	1	16	Histopathologic	Histopathologic	JJ	B-NP
O	17	28	examination	examination	NN	I-NP
O	29	31	of	of	IN	B-PP
B-Cancer	32	38	rectal	rectal	JJ	B-NP
I-Cancer	39	48	carcinoma	carcinoma	NN	I-NP
O	48	49	]	]	)	O
O	49	50	.	.	.	O

O	51	53	In	In	IN	B-PP
O	54	62	patients	patient	NNS	B-NP
O	63	67	with	with	IN	B-PP
B-Cancer	68	74	rectal	rectal	JJ	B-NP
I-Cancer	75	84	carcinoma	carcinoma	NN	I-NP
O	84	85	,	,	,	O
O	86	89	the	the	DT	B-NP
O	90	107	histopathological	histopathological	JJ	I-NP
O	108	118	evaluation	evaluation	NN	I-NP
O	119	121	of	of	IN	B-PP
O	122	125	the	the	DT	B-NP
B-Cancer	126	134	surgical	surgical	JJ	I-NP
I-Cancer	135	143	specimen	specimen	NN	I-NP
O	144	152	provides	provide	VBZ	B-VP
O	153	160	pivotal	pivotal	JJ	B-NP
O	161	171	prognostic	prognostic	JJ	I-NP
O	172	175	and	and	CC	I-NP
O	176	187	therapeutic	therapeutic	JJ	I-NP
O	188	199	information	information	NN	I-NP
O	199	200	.	.	.	O

O	201	210	Important	Important	JJ	B-NP
O	211	221	parameters	parameter	NNS	I-NP
O	222	225	are	be	VBP	B-VP
B-Cancer	226	231	tumor	tumor	NN	B-NP
I-Cancer	232	236	site	site	NN	I-NP
I-Cancer	236	237	,	,	,	O
O	238	243	depth	depth	NN	B-NP
O	244	246	of	of	IN	B-PP
O	247	255	invasion	invasion	NN	B-NP
O	255	256	,	,	,	O
O	257	269	histological	histological	JJ	B-NP
O	270	274	type	type	NN	I-NP
O	275	278	and	and	CC	I-NP
O	279	284	grade	grade	NN	I-NP
O	284	285	,	,	,	O
O	286	293	pattern	pattern	NN	B-NP
O	294	296	of	of	IN	B-PP
O	297	305	invasion	invasion	NN	B-NP
O	306	307	(	(	(	O
O	307	316	diffusely	diffusely	RB	B-VP
O	317	329	infiltrating	infiltrate	VBG	I-VP
O	330	336	versus	versus	IN	B-PP
O	337	346	expanding	expand	VBG	B-VP
O	347	353	margin	margin	NN	B-NP
O	353	354	)	)	)	O
O	354	355	,	,	,	O
O	356	362	degree	degree	NN	B-NP
O	363	365	of	of	IN	B-PP
B-Cell	366	377	peritumoral	peritumoral	JJ	B-NP
I-Cell	378	389	lymphocytic	lymphocytic	JJ	I-NP
O	390	402	infiltration	infiltration	NN	I-NP
O	402	403	,	,	,	O
O	404	407	and	and	CC	O
B-Cancer	408	413	tumor	tumor	NN	B-NP
O	414	425	involvement	involvement	NN	I-NP
O	426	428	of	of	IN	B-PP
B-Tissue	429	437	surgical	surgical	JJ	B-NP
I-Tissue	438	445	margins	margin	NNS	I-NP
O	446	449	and	and	CC	O
B-Multi-tissue_structure	450	455	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	456	461	nodes	node	NNS	I-NP
O	461	462	.	.	.	O

O	463	473	Evaluation	Evaluation	NN	B-NP
O	474	476	of	of	IN	B-PP
O	477	480	the	the	DT	B-NP
B-Tissue	481	496	circumferential	circumferential	JJ	I-NP
I-Tissue	497	498	(	(	(	O
I-Tissue	498	502	deep	deep	JJ	B-ADJP
I-Tissue	502	503	,	,	,	O
I-Tissue	504	511	lateral	lateral	JJ	B-ADJP
I-Tissue	511	512	)	)	)	O
I-Tissue	513	519	margin	margin	NN	B-NP
O	520	522	is	be	VBZ	B-VP
O	523	525	of	of	IN	B-PP
O	526	532	utmost	utmost	JJ	B-NP
O	533	543	importance	importance	NN	I-NP
O	543	544	.	.	.	O

O	545	547	It	It	PRP	B-NP
O	548	554	should	should	MD	B-VP
O	555	557	be	be	VB	I-VP
O	558	565	labeled	label	VBN	I-VP
O	566	570	with	with	IN	B-PP
O	571	574	ink	ink	NN	B-NP
O	575	577	in	in	IN	B-PP
O	578	581	the	the	DT	B-NP
B-Cancer	582	587	gross	gross	JJ	I-NP
I-Cancer	588	596	specimen	specimen	NN	I-NP
O	597	600	and	and	CC	O
O	601	607	should	should	MD	B-VP
O	608	610	be	be	VB	I-VP
O	611	619	examined	examine	VBN	I-VP
O	620	634	histologically	histologically	RB	B-ADVP
O	635	640	using	use	VBG	B-VP
O	641	648	several	several	JJ	B-NP
B-Tissue	649	655	tissue	tissue	NN	I-NP
O	656	662	blocks	block	NNS	I-NP
O	662	663	.	.	.	O

O	664	667	The	The	DT	B-NP
O	668	674	number	number	NN	I-NP
O	675	677	of	of	IN	B-PP
B-Cancer	678	683	lymph	lymph	NN	B-NP
I-Cancer	684	688	node	node	NN	I-NP
I-Cancer	689	699	metastases	metastasis	NNS	I-NP
O	700	703	and	and	CC	O
O	704	707	the	the	DT	B-NP
O	708	713	total	total	JJ	I-NP
O	714	720	number	number	NN	I-NP
O	721	723	of	of	IN	B-PP
B-Multi-tissue_structure	724	729	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	730	735	nodes	node	NNS	I-NP
O	736	744	examined	examine	VBN	B-VP
O	745	751	should	should	MD	B-VP
O	752	754	be	be	VB	I-VP
O	755	763	reported	report	VBN	I-VP
O	763	764	.	.	.	O

O	765	766	A	A	DT	B-NP
O	767	779	histological	histological	JJ	I-NP
O	780	790	evaluation	evaluation	NN	I-NP
O	791	793	of	of	IN	B-PP
O	794	797	the	the	DT	B-NP
B-Multi-tissue_structure	798	804	distal	distal	JJ	I-NP
I-Multi-tissue_structure	805	815	mesorectum	mesorectum	NN	I-NP
O	816	818	in	in	IN	B-PP
O	819	822	its	its	PRP$	B-NP
O	823	831	entirety	entirety	NN	I-NP
O	832	834	is	be	VBZ	B-VP
O	835	846	recommended	recommend	VBN	I-VP
O	847	849	to	to	TO	I-VP
O	850	856	detect	detect	VB	I-VP
O	857	870	discontinuous	discontinuous	JJ	B-NP
B-Cancer	871	877	distal	distal	JJ	I-NP
I-Cancer	878	888	mesorectal	mesorectal	JJ	I-NP
I-Cancer	889	894	tumor	tumor	NN	I-NP
O	895	901	spread	spread	NN	I-NP
O	901	902	.	.	.	O

O	903	906	The	The	DT	B-NP
O	907	924	histopathological	histopathological	JJ	I-NP
O	925	933	findings	finding	NNS	I-NP
O	934	940	should	should	MD	B-VP
O	941	943	be	be	VB	I-VP
O	944	954	summarized	summarize	VBN	I-VP
O	955	960	using	use	VBG	B-VP
O	961	964	the	the	DT	B-NP
O	965	968	TNM	TNM	NN	I-NP
O	968	969	-	-	HYPH	I-NP
O	969	983	classification	classification	NN	I-NP
O	983	984	.	.	.	O

